Prednisone alone

( DrugBank: Prednisone / KEGG DRUG: Prednisone )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
11	重症筋無力症	2

告示番号	疾患名（ページ内リンク）	臨床試験数
66	IgA腎症	5

11. 重症筋無力症

臨床試験数 : 332 / 薬物数 : 234 - (DrugBank : 81) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 127

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR1800017564	2018-09-08	2018-08-04	Optimal Timing of Thymectomy in Nonthymomatous Myasthenia Gravis Patients In China: A Follow-up Pros ...	Optimal Timing of Thymectomy in Nonthymomatous Myasthenia Gravis Patients In China: A Prospective St ...	Myasthenia Gravis	Experiment group versus Control group:Thymectomy plus oral prednisone, an immunosuppressant protocol ...	The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine	NULL	Pending	1	80	Both	Experiment group versus Control group:822;		China
2	NCT00294658 (ClinicalTrials.gov)	June 2006	21/2/2006	Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy	A Multi-Center, Single-Blind, Randomized Study Comparing Thymectomy to No Thymectomy in Non-Thymomat ...	Myasthenia Gravis	Procedure: thymectomy plus prednisone;Drug: prednisone alone	University of Alabama at Birmingham	National Institute of Neurological Disorders and Stroke (NINDS)	Completed	18 Years	65 Years	All	126	Phase 3	United States;Argentina;Australia;Brazil;Canada;Chile;Germany;Italy;Japan;Mexico;Netherlands;Poland; ...

First Previous1Next Last

66. IgA腎症

臨床試験数 : 275 / 薬物数 : 258 - (DrugBank : 82) / 標的遺伝子数 : 36 - 標的パスウェイ数 : 140

trials per page:

Showing 1 to 5 of 5 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03218852 (ClinicalTrials.gov)	December 2016	7/12/2016	Extended Follow-up of Treatment of PrednisonePlus Cyclophosphamide in Patients With Advanced-stage I ...	An Extended Follow-up of the Prospective Randomized, Controlled, Open-labeled Trial of PrednisonePlu ...	IgA Nephropathy	Drug: prednisone and cyclophosphamide;Drug: prednisone alone	Guangdong General Hospital	NULL	Active, not recruiting	18 Years	70 Years	All	133	Phase 4	China
2	NCT01758120 (ClinicalTrials.gov)	December 2012	12/12/2012	Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy	A Prospective Randomized, Controlled, Open-labeled Trial of PrednisonePlus Cyclophosphamide in Patie ...	IgA Nephropathy	Drug: prednisone plus cyclophosphamide;Drug: Prednisone alone	Guangdong General Hospital	NULL	Active, not recruiting	18 Years	70 Years	All	135	Phase 4	China
3	ChiCTR-TRC-10000824	2010-01-01	2010-04-06	the clinical effect of Fufang Shenyan Tablet on IgA Nephropathy patients	Multicenter, randomized, double-blind, placebo-controlled clinical research of the clinical effect o ...	IgA Nephropathy	the control group:The 24-hour urinary protein 0.5-2.0g: Lotensin 10mg, bid; placebos 2.5g tid; The 2 ...	The First Affiliated Hospital of Xi'an Jiaotong University Medical College	NULL	Completed	18	65	Both	the control group:60;the treatment group:60;		China
4	ChiCTR-TRC-06000004	2006-01-01	2006-09-14	ACEi/ARB aloneversus ACEi/ARB plus Steroids in the treatment of primary IgA nephropathy, a randomize ...	ACEi/ARB aloneversus ACEi/ARB plus Steroids in the treatment of primary IgA nephropathy, a randomize ...	primary IgA nephropathy	group 1:treated with ACEI/ARB( ARB therapy is subjected to patients with cough after use of ACEI) In ...	The First Hospital, Peking University	NULL	Completed	16	65	Both	group 1:78;group 2:78;		China
5	NCT00378443 (ClinicalTrials.gov)	January 2006	19/9/2006	ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT		Glomerulonephritis, IGA	Drug: prednisone + Inhibace/Cozaar;Drug: Inhibace/Cozaar	Peking University	NULL	Active, not recruiting	16 Years	65 Years	Both		N/A	NULL

First Previous1Next Last